Parallel Learning raised a $20M Series B funding round. The round was led by Valspring Capital, with additional capital ...

Contributing factors include the inappropriate prescribing and use of asthma medication. A recent report from the United Kingdom, prepared by the National Review of Asthma Deaths, aimed to identify ...

No one likes to be reminded that their largest organ is a veritable menagerie of microbes. But Parallel Health turns the skin microbiome from creepy fact to potentially transformative skin care by ...

Early aggressive treatment of rheumatoid arthritis is associated with improved disease control, slower radiological progression and improved functional outcomes. Tumor necrosis factor blocking therapy ...